Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia : a phase 1-2 study

• COIFFIER B

収録刊行物

• Blood

  Blood 111 1094-1100, 2008

詳細情報

• CRID: 1572543024900715904
• NII論文ID: 10029614891
• データソース種別:
  • CiNii Articles